Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. MNMD MMED MMQ announced Friday the initiation of Phase 2a proof-of-concept trial of LSD (lysergic acid diethylamide) in adult patients ...

I became a neuroscientist to help us understand how humans gain deeper insight and observation into themselves, life, and being during altered states of consciousness. I never expected to write a post ...

Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...

LSD and psilocybin are known for their capacity to enhance the complexity or “diversity” of brain activity. But does THC work in the same way? A recent study spearheaded by Conor Murray at the ...

Add Yahoo as a preferred source to see more of our stories on Google. Better moods, higher concentration levels, more creativity - and all without the usual risks associated with hard drugs: ...

Microdosing psychedelics has received growing attention in recent years, as it’s been said to enhance creativity, increase focus, and lift the weight of depression. Now, scientists want to figure out ...

A little bit of hallucinogen can go a long way in alleviating physical pain. New research has found that a microdose of lysergic acid diethylamide (LSD) significantly increases human pain tolerance ...

After a several years of bubbling just beneath the surface, psychedelic drugs are having their latest moment of public acceptance. Meanwhile, groups as disparate as Silicon Valley executives and ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. It may seem like a doomed attempt to mix business and pleasure. But a ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. We just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very ...